XORTX Therapeutics Calls Special Meeting of Shareholders
CALGARY, Alberta, Aug. 13, 2021 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”)…
Month: August 2021
Biophytis Announces the Issue of 4,950,000 New Shares in a Capital Increase Reserved for NEGMA and the Performance of the Judgments of March 16, 2021 and July 16, 2021
PARIS and CAMBRIDGE, Mass., Aug. 13, 2021 (GLOBE NEWSWIRE) — Biophytis SA (NasdaqCM: BPTS, Euronext…
Entera Bio to Report Business and Financial Results for the Quarter ended June 30, 2021, on August 16, 2021
BOSTON and JERUSALEM, Aug. 13, 2021 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), a…
Employee Elected Director to step down from the board of Zealand Pharma A/S
Company announcement No. 51 / 2021 Employee Elected Director to step down from the board…
Rani Therapeutics Announces Closing of its Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
SAN JOSE, Calif., Aug. 13, 2021 (GLOBE NEWSWIRE) — Rani Therapeutics Holdings, Inc. (Nasdaq:RANI) (“Rani…
XcelPlus International exhibits at Mining Disrupt 2021, solicits partnerships with crypto miners
RENO, NV, Aug. 13, 2021 (GLOBE NEWSWIRE) — XcelPlus International Inc. (OTC PINK: XLPID) announced today…
Theratechnologies Announces Publication of TH1902 Preclinical Data in Peer-Reviewed Journal, Cancer Science
MONTREAL, Aug. 13, 2021 (GLOBE NEWSWIRE) — Theratechnologies, Inc. (Theratechnologies, or Company) (TSX: TH) (NASDAQ:…
Recro Announces Acquisition of San Diego-based IRISYS, Creating Bi-Coastal, Full Service CDMO
Combination of Synergistic Organizations Results in Broad CDMO Service with Capabilities Spanning from Pre-IND Development…
Outlook Therapeutics Reports Financial Results for Third Quarter of Fiscal Year 2021 and Provides Corporate Update
Reported positive, statistically significant top-line efficacy and safety data from pivotal Phase 3 NORSE TWO…
Ayala Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Update
– Enrolled the First Patient in the Phase 2/3 Pivotal Trial of AL102 for the…
Trigone Pharma Announces the Initiation of a Phase 2 Clinical Trial of TRG-100 in Patients with Interstitial Cystitis/Bladder Pain Syndrome
TRG-100 is now being evaluated in broad range of bladder disorders RAANANA, Israel, Aug. 13,…
PMV Pharmaceuticals Reports Second Quarter 2021 Financial Results and Corporate Highlights
Continued enrollment in Phase 1/2 trial of first-in-class p53 Y220C reactivator PC14586 CRANBURY, N.J., Aug….
Alimera Sciences Announces Second Quarter 2021 Financial Results
Consolidated Net Revenue of $21.7 Million up 117% vs. Second Quarter of 2020 Consolidated Net…
Spectral Announces Second Quarter Results and Provides Corporate Update
TORONTO, Aug. 13, 2021 (GLOBE NEWSWIRE) — Spectral Medical Inc. (“Spectral” or the “Company”) (TSX:…
BioCardia to Participate in Upcoming Investor Conferences
SAN CARLOS, Calif., Aug. 13, 2021 (GLOBE NEWSWIRE) — BioCardia®, Inc. (Nasdaq: BCDA), a developer of…
Plus Therapeutics to Present Data from ReSPECT™-GBM Trial at the American Association of Neurological Surgeons 2021 Annual Scientific Meeting
AUSTIN, Texas, Aug. 13, 2021 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a…
Alpha Healthcare and Humacyte Announce Nominees for Election to Post-Merger Public Company Board of Directors
Nominees bring depth and diversity of scientific, commercial and financial experience to Board NEW YORK…
ContraFect Reports Second Quarter 2021 Financial Results and Provides Business Update
Multiple peer-reviewed journal publications and presentations at scientific forums drive value and recognition across the…
HCW Biologics Reports Second Quarter Financial Results and Recent Business Highlights
MIRAMAR, Fla., Aug. 13, 2021 (GLOBE NEWSWIRE) — HCW Biologics Inc. (the “Company”) (NASDAQ: HCWB),…
POINT Biopharma Reports Second Quarter 2021 Financial Results and Provides Business Update
Strengthened the Company’s balance sheet by completing the business combination with Therapeutics Acquisition Corp (“RACA”),…